Adam Kaplin
Director/Board Member at Cody Unser First Step Foundation
Net worth: 220 000 $ as of 2024-03-30
Profile
Adam Kaplin is the founder of MIRA Pharmaceuticals, Inc., which was founded in 2020.
He held the title of President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also currently working at The Johns Hopkins University as the Director of the Johns Hopkins Ketamine Clinic since 2002.
Additionally, he is the Director of Cody Unser First Step Foundation since 2005.
Previously, Dr. Kaplin worked as the Chief Scientific Officer at MyMD Pharmaceuticals, Inc. from 2020 to 2024.
Dr. Kaplin obtained his doctorate degree from The Johns Hopkins University in 1996 and his undergraduate degree from Yale University in 1988.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-08-02 | 200,000 ( 1.35% ) | 220 000 $ | 2024-03-30 | |
2024-03-28 | 0 ( -.--% ) | - $ | 2024-03-30 |
Adam Kaplin active positions
Companies | Position | Start |
---|---|---|
The Johns Hopkins University | Corporate Officer/Principal | 2001-12-31 |
Cody Unser First Step Foundation | Director/Board Member | 2004-12-31 |
Former positions of Adam Kaplin
Companies | Position | End |
---|---|---|
MYMD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2024-04-14 |
MIRA PHARMACEUTICALS, INC. | Founder | 2024-03-06 |
Training of Adam Kaplin
The Johns Hopkins University | Doctorate Degree |
Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MYMD PHARMACEUTICALS, INC. | Health Technology |
MIRA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Cody Unser First Step Foundation |
- Stock Market
- Insiders
- Adam Kaplin